Kioxia Holdings Corp. launched a leveraged product in Hong Kong on Tuesday, the first single-stock instrument in the city since a volatile SK Hynix Inc. product drew regulatory scrutiny in 2025. The CSOP KIOXIA Daily Max 1.25x Leveraged Product uses a swap-based synthetic replication strategy to target a 1.25x daily return of Kioxia's common shares, with a lower leverage cap than peers offering up to 2x exposure. The most recent similar listing, the CSOP SK Hynix Daily Max 2x Leveraged Product, reached nearly $17 billion in assets before sparking controversy over market turbulence and retail losses, prompting regulators in Korea and Hong Kong to revise rules.
Analyst Rebecca Sin of Bloomberg Intelligence noted strong demand for semiconductor exposure but said moderate leverage tiers like 1.25x or 1.5x struggle to attract retail traders compared to higher-leveraged structures. Kioxia's Tokyo-listed shares, which have more than doubled year-to-date, fell roughly 75% from their June record high as investor interest shifted away from artificial intelligence plays amid macro headwinds and geopolitical uncertainty.
Source: Bloomberg Markets · Summarized by HeadlinesBriefing